Ahmed Ebada Salem, MBBCh, MSc, MD-PhD
Department of Nuclear Medicine, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Director of Education, Department of Nuclear Medicine, Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of Nuclear Medicine, Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2022 | Alexandria University, Alexandria, EG, Doctorate degree in Diagnostic Radiology, MD-PhD |
| 2015 | Alexandria University, Alexandria, EG, Master's Degree in Diagnostic Radiology, MSc |
| 2009 | Alexandria University, Alexandria, EG, Bachelor of Medicine and Bachelor of Surgery (MBBCh) |
Postgraduate Training
| 2021-2022 | Clinical Fellow, Nuclear Radiology, The University of Utah, Salt Lake City, Utah |
| 2020-2021 | Clinical Fellow, Abdominal Imaging, The University of Utah, Salt Lake City, Utah |
| 2019-2020 | Clinical Fellow, Nuclear Medicine, The University of Utah, Salt Lake City, Utah |
| 2017-2019 | Research Fellow, Nuclear Radiology, Huntsman Cancer Institute - The University of Utah, Salt Lake City, Utah |
| 2016-2022 | Post Graduate Student - Doctorate degree in Diagnostic Radiology, Faculty of Medicine, Alexandria University, Alexandria, Alexandria |
| 2016-2022 | Post Graduate Student - Doctorate degree in Diagnostic Radiology, MD-PhD, Diagnostic Radiology, Alexandria University, Alexandria |
| 2016-2017 | Visiting Scholar, Nuclear Radiology, University of Utah, Salt Lake City, Utah |
| 2014-2014 | Clinical Observership, Interventional Radiology, Royal Victoria Hospital, Montreal |
| 2013-2013 | Clinical Observership, Interventional Radiology, Memorial Sloan Kettering Cancer Center, New York, New York |
| 2011-2015 | Physician Resident, Diagnostic Radiology, Alexandria University, Alexandria |
| 2011-2015 | Post Graduate Student - Masters Degree, Diagnostic Radiology, Alexandria University, Alexandria |
| 2010-2011 | Intern, Diagnostic Radiology, Alexandria University, Alexandria |
| 2009-2010 | Internship, Virchow Campus Humboldt University, Berlin |
| 2003-2009 | Undergrad, MBBCh, Alexandria University, Alexandria |
Licenses & Certifications
| 2024 | Texas State Medical License |
| 2024 | American Board of Radiology (ABR), Certificate of Added Qualification in Nuclear Radiology |
| 2023 | Advanced Cardiac Life Support (ACLS) |
| 2023 | American Board of Nuclear Medicine |
| 2023 | Florida State Medical License |
| 2022 | American board of Radiology (ABR) |
| 2019 | Basic Life Support (BLS) |
| 2019 | Controlled Substance |
| 2019 | Utah State Medical License |
Experience & Service
Faculty Academic Appointments
Education Lead, Department of Radiology and Imaging Sciences, The University of Utah, Salt Lake City, UT, 2022 - 2024
Clinical Assistant Professor, Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT, 2022 - 2024
Co-Investigator, Huntsman Cancer Institute, The University of Utah, Salt Lake City, UT, 2022 - 2024
Research Associate, Center for Quantitative Cancer Imaging, Huntsman Cancer Institute, Salt Lake City, UT, 2017 - 2019
Assistant Lecturer, Department of Radiology, Faculty of Medicine, The University of Alexandria, Alexandria, 2015 - 2022
Lecturer, Department of Radiology, Faculty of Medicine, The University of Alexandria University, Alexandria, 2015 - 2016
Clinical Demonstrator, Department of Radiology, Faculty of Medicine, The University of Alexandria, Alexandria, 2015 - 2016
General Practitioner, Egypt Ministry of Health, Cairo, 2011
Extramural Institutional Committee Activities
Member, DI Planning Committee for Education, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, DI Educational Functional Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Panel Reviewer, Radiographics Nuclear Radiology Subspecialty, Radiological Society of North America, 2026 - Present
Member, DI Faculty Functional Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Editorial Activities
Panel Reviewer, RSNA Nuclear radiology educational Exhibit Review Committee, 2026 - Present
Abstract Reviewer, RSNA Nuclear radiology educational Exhibit Review Committee, 2026 - Present
Abstract Reviewer, RSNA Neuroradiology educational Exhibit Review Committee, 2025 - Present
Editorial Board Member, Cancer Imaging (Springer Nature / BMC), 2024 - Present
Abstract Reviewer, Nuclear Radiology Educational Exhibit Review Committee, 2024 - Present
Reviewer, European Journal of Nuclear Medicine and Molecular Imaging, 2021 - Present
Honors & Awards
| 2026 | Recognized as Ones to Watch for 2026 by SNMMI, National recognition of early career professionals who show exceptional potential as future leaders in nuclear medicine and molecular imaging; selected from member nominations by the SNMMI Future Leaders Working Group and SNMMI-TS Professional Development Committee |
| 2025 | Excellence in Safety award program, MD Anderson's Excellence in Safety Award (November 2025) as a member of a multidisciplinary team that developed a novel protocol for giving I-131 therapy by PEG tube. The patient had severe dysphagia and airway compromise and had been declined treatment at multiple other institutions. The approach, rarely described in the literature, kept dosing and pharmacokinetics intact while minimizing radiation safety risks |
| 2025 | Certificate of Merit, 111th Scientific Assembly and Annual Meetings of the Radiologic Society of North America, RSNA |
| 2025 | Certificate of Merit, 111th Scientific Assembly and Annual Meetings of the Radiologic Society of North America, RSNA |
| 2017 | Cum Laude, 105th Scientific Assembly and Annual Meetings of the Radiologic Society of North America |
| 2017 | Egyptian Ministry of Higher Education Grant, Egyptian Ministry of Higher Education |
| 2017 | Certificate of Merit, 105th Scientific Assembly and Annual Meetings of the Radiologic Society of North America |
| 2015 | Best International Scientific Publication, Alexandria University |
| 2009 | M.B.B.Ch. Faculty of Medicine, Graduated with honors and overall grade of Excellent, ranked 13 out of 1175, Medical Student, Alexandria University, Egypt |
Professional Memberships
Selected Presentations & Talks
National Presentations
- 2026. THE EXPANDING THERANOSTICS ROADMAP:FROM ESTABLISHED THERAPIES TO NEXT-GENERATION PIPELINES. Poster. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. RENAL SCINTIGRAPHY: PRINCIPLES, PROTOCOLS, AND CLINICAL APPLICATIONS A PRACTICAL IMAGING GUIDE. Conference. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. Cancer Therapy in the Modern Era: Abdominal and Pelvic Complications of Immunotherapy and Targeted Agents. Poster. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. Multi-Modality Imaging of the Small-Bowel Mesenteric Root: Anatomic Landmarks, Pathologic Spectrum, Patterns of Disease Spread, and Imaging Pitfalls. Conference. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. SMALL VESSELS, BIG CONSEQUENCES: MULTIMODALITY IMAGING REVIEW OF PULMONARY TUMOR THROMBOTIC MICROANGIOPATHY (PTTM). Conference. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. F-18 FDG PET-CT, BEYOND ONCOLOGY: CURRENT UTILITY AND FUTURE DIRECTIONS IN MANAGEMENT OF INFECTION AND INFLAMMATION. Conference. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. The role of DWI/ADC in malignant biliary obstruction, ideally with corresponding MRCP and postcontrast images. Conference. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. ¹⁸F-FDG PET/CT IDENTIFICATION OF PERIPHERAL NERVE SHEATH DISORDERS AND PERINEURAL TUMOR SPREAD. Poster. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. THE EXPANDING THERANOSTICS ROADMAP:FROM ESTABLISHED THERAPIES TO NEXT-GENERATION PIPELINES. Conference. Radiologic Society of North America 2026. Chicago, Illinois, US.
- 2026. Navigating the WHO-HEAM5 Lymphoma Landscape: An Imaging Primer for Hematologists. Poster. 14th Annual Meeting of the Society of Hematologic Oncology (SOHO).
- 2025. “Misguided Missiles”: When Radiotracers Wander Off Course. Poster. 111th RSNA Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. Functional Adrenal Pathologies: Imaging Approach to Endocrine Clinical and Biochemical Phenotypes. Invited. 111th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. V/Q Scintigraphy: More Than a PE Scan – Know the Patterns, Avoid the Traps!. Invited. 111th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. The Clinical Utility Of PET-CT In Hereditary Cancer Syndromes: Advancing Screening, Diagnosis and Management. Educational exhibit. Invited. 111th Scientific Assembly and Annual Meetings of the RSNA. Chicago, Illinois, US.
- 2025. The Blood’s New Alphabet: Critical Insights for Radiologists in Understanding the New WHO Lymphoma Classification. 111th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. Beyond Osseous Metastasis: Deep Dive into Bone Scintigraphy. Conference. 111th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. Adipose Tissue: Normal Variants and Pathologic Insights on 18F-FDG PET/CT. Conference. 111th Scientific Assembly and Annual Meetings of the RSNA. Chicago, Illinois, US.
- 2025. Where The Light Betrays: Immunotherapy-Related Adverse Events (irAEs) on 18F-FDG PET/CT. Invited. 111th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. “Misguided Missiles”: When Radiotracers Wander Off Course. Invited. 111th RSNA Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2025. The Forgotten Territory: The Blind Spot in Oncologic PET/CT – Why Overlooked?. Invited. 111th Scientific Assembly and Annual Meeting. Chicago Ridge, Illinois, US.
- 2023. SVC obstruction and Hot Quadrate sign. Salt Lake City, Utah, US.
- 2021. Unusual sites of prostate cancer recurrence, incidentals, second primary malignancies, physiologic variants, and pitfalls on 18F-Fluciclovine PET/CT: pictorial review. Invited. 107th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2019. Sciatic Foramen Lesions: Anatomic Considerations and Pathologic Conditions. Invited. 105th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2019. Comparison of the Diagnostic Role of Imaging-Guided Biopsy Techniques in Lymphadenopathy. Invited. 49th Annual Meeting of the American Society of Head and Neck Radiology. Naples, Florida, US.
- 2019. What the Radiologist Needs to Know. ARRS. Honolulu, Hawaii.
- 2019. What the Radiologist Needs to Know about High-Grade B-cell Lymphoma (HGBL). Invited. 119th Annual Meeting. Honolulu, Hawaii, US.
- 2019. High Grade B-Cell Lymphoma (HGBL) in the Abdomen and Pelvis: What the Radiologist Needs to Know. Invited. European Society of Radiology, AT.
- 2018. Female Pelvic Inflammatory Disease: From Simple Salpingitis to Xanthogranulomatous Oophoritis. Invited. 104th Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2017. When the Pathologist Asks, 'Are You Sure You Are Biopsying the Liver?' Unusual Hepatic Tumor and Tumor-Like Conditions: Clinical, Pathological, and Imaging Features. Invited. 103rd Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2017. Lipopolysaccharide Endotoxemia Results in Secondary Neuroinflammation and Deposition of Amyloid Beta and Phosphorylated Tau in the Rat. Invited. 103rd Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
- 2015. Multimodality Imaging of Extrahepatic Biliary Obstruction: Causes, Clinical Aspects, and Imaging Features. Invited. 103rd Scientific Assembly and Annual Meeting. Chicago, Illinois, US.
International Presentations
- 2026. PET-CT Technique, Uses and Imaging Pitfalls. Invited. Annual Conference of the Department of Radiology. Alexandria, EG.
- 2024. Introduction to PET/CT. Invited. Annual Conference of the Department of Radiology. Alexandria, EG.
- 2024. Role of PET-CT in Hematologic Malignancies. Invited. Annual Conference of the Department of Radiology. Alexandria, EG.
- 2024. Role of PET-CT in Thoracic Malignancies. Invited. Annual Conference of the Department of Radiology. Alexandria, EG.
- 2023. DOTATATE PET/CT Imaging in Prostate Cancer: Incidental Observations and Potential Future Applications. Invited. Multidisciplinary NET Medical Symposium, NANETS, CA.
- 2019. High Grade B-Cell Lymphoma (HGBL) in the Abdomen and Pelvis: What the Radiologist Needs to Know. Invited. European Society of Radiology (ESR 2019). Vienna, AT.
- 2016. Non-vascular Interventional Radiology Procedures. Invited. 16th Annual Meeting of the Mediterranean and African Society of Ultrasound, EG.
- 2016. Retroperitoneal Intranodal Contrast Injection for Lymphangiographic Imaging of the Thoracic Duct in View of Percutaneous Intervention. Invited. 16th Annual Meeting of the Mediterranean and African Society of Ultrasound. Alexandria, EG.
- 2016. Ultrasound-Guided Biopsies in Lymphadenopathies. Invited. 16th Annual Meeting of the Mediterranean and African Society of Ultrasound. Alexandria, EG.
- 2009. Immunity and Infertility. Invited. 23rd Annual Scientific Meeting for Women’s Health, EG.
Formal Peers
- 2025. Nuclear Medicine Faculty Interesting Case Conference. Houston, Texas.
- 2025. Presenting at the Diagnostic Imaging Educational Case Conference. Houston, Texas, US.
Grant & Contract Support
| Date: | 2025 |
| Title: | Role of FDG PET-CT in management of renal medullary cancers- Retrospective analysis |
| Funding Source: | Jpn J Radiol |
| Role: | Co-I |
| ID: | PA16-0736 |
| Date: | 2023 - 2024 |
| Title: | ETCTN 10450 Ph Ib Peposertib + Lutetium 177 Dotatate |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 146425 |
| Date: | 2023 - 2024 |
| Title: | RayzeBio RYZ101-301 (SIRB) >> Phase Ib/III global, randomized, controlled, openlabel trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+), well-differentiated gastronteropancreatic neuroendocrine tumors (GEP-NETs) that have progressed following prior treatment with 177Lu-DOTATATE or 177Lu-DOTATOC (177Lu- DOTATATE/TOC) (ACTION-1) |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | RYZ101-301 |
| Date: | 2022 - 2024 |
| Title: | IIT Rad2Nivo Ph Ib/II Rad-223 + Nivo Met Prostate Cancer |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 126006 |
| Date: | 2022 - 2024 |
| Title: | Alliance A031801 Ph II Radium-223 + Carbo Adv RCC |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 153119 |
| Date: | 2022 - 2024 |
| Title: | Janssen HOXTON Ph I Actinium-225 Prostate Cancer |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 158165 |
| Date: | 2022 - 2024 |
| Title: | IIT CaboLu Ph Ib Cabo + Lutetium -177 Prostate Cancer |
| Funding Source: | University of Utah |
| Role: | PI |
| ID: | 157278 |
| Date: | 2022 - 2024 |
| Title: | A021901 Ph II Lutetium Lu 177 Dotatate vs Everolimus |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 148408 |
| Date: | 2022 - 2024 |
| Title: | RayzeBio RYZ101-101 Ph Ib RYZ101 w carbo + etop + atezo SSTR + |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 163075 |
| Date: | 2022 - 2024 |
| Title: | COMPOSE ITM DP-1111-02CT PRRT w Lutetium 177Lu Edotreotide |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 165072 |
| Date: | 2022 - 2024 |
| Title: | ETCTN 10558Ph II Triapine + Lu177 Dotatee vs LU177 alone |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 168484 |
| Date: | 2022 - 2024 |
| Title: | Ph II Lutetium Lu 177 Dotate PRRT vs Chemo |
| Funding Source: | University of Utah |
| Role: | Co-I |
| ID: | 156858 |
Selected Publications
Peer-Reviewed Articles
- Wang E, Salem A, Palaskas NL, Sahay S, Bernardo R, Brehm VLD, Luis E, Brito CD, Lee G, Gabr E, Ali A, Deswal A, Krebs S, Faiz S. A Systematic Review of Pulmonary Tumor Thrombotic Microangiopathy: Updates and Future Directions (CHEST-D-26-04238). e-Pub 2026.
- Krebs S, Jonasch E, Campbell MT, Salem A, Nguyen NC, Sheth RA, Karam JA, Daw NC, Tang C, Tannir NM, Surasi DS, Msaouel P. Exploiting the Krebs Cycle Defect: [18F]FDG PET/CT for Extent of Disease Evaluation and Treatment Management in Fumarate Hydratase-Deficient Renal Cell Carcinoma. e-Pub 2026.
- Salem A, Wang M, Camacho F, Faiz S, Ali N, Hussein A, Shaaban AM, Rogers D, Morton K, El-Sayes K, Elkahneny A, Ali H, Krebs S. Pulmonary Tumor Emboli Syndrome: Multimodality Imaging Signature from a Cohort Study of 12 Patients. e-Pub 2026.
- Krebs S, Salem A, Nguyen NC, Sheth RA, Karam JA, Daw NC, Tang C, Tannir NM, Msaouel P, Surasi DS. Role of FDG PET-CT in management of renal medullary cancers- Retrospective analysis. J Nucl Med 67(9):1372 - 1378, 2026. e-Pub 2026. PMID: 42315313.
- Eissa, MM, Salem, AE, El Skhawy, N. Parasites revive hope for cancer therapy. European journal of medical research 29(1):489, 2024. e-Pub 2024. PMID: 39367471.
- Wang, Wu, Kirk, Horn, Salem A, Hoffman, Yap, Sonnen, Towner, Bozza, Rodrigues, Morton. Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain. Am J Nucl Med Mol Imaging 8(2):86 - 99, 2018. e-Pub 2018. PMID: 29755842.
Review Articles
- Weller, JH, Lincango, E, Butler, JJ, Salem, AE, Elsayes, KM, Perrier, ND. Important Advances in Adrenal Pathologic Classification, Imaging Analysis, and Systemic Therapy. Current Surgery Reports 14(1), 2026. e-Pub 2026.
- Tang, C, Sadiq, M, Ravizzini, G, Salem, AE. Current Applications of Molecular Imaging in Adrenal Imaging. Magnetic resonance imaging clinics of North America 33(4):595-612, 2025. e-Pub 2025.
- Salem A, Elbanna A, Diab M, Krebs S, Gaballah M, Mourad T, Kassem N, Cho S, Shaaban A, Elsayes K, Morton K. WHO-HAEM5 Lymphoid Neoplasms: ¹⁸F-FDG PET/CT and Imaging Insights for Radiologists (ID# RG-26-0083.R1), for publication in RadioGraphics. e-Pub 2025.
- Stanietzky N, Salem A, Elsayes KM, Rezvani M, Fraivillig K, Salem U, Klimkowski S, Diab M, Naik S, Sobieh A, Menias CO, Shaaban AM. Tumor-like conditions that mimic liver tumors. Diagn Interv Radiol 31(4):285-294, 2025. e-Pub 2025. PMID: 38874132.
- Stanietzky N, Salem A, Elsayes K, Rezvani M, Palmquist S, Ahmed I, Marey A, Faria Silvana, Gaballah AH, Menias CO, Shaaban AM. Unusual liver tumors: Spectrum of Imaging findings with pathologic correlation. Diagn Interv Radiol 31(2):58-67, 2025. e-Pub 2025. PMID: 38856323.
- Salem AE, Shah HR, Covington MF, Koppula BR, Fine GC, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies. Cancers (Basel) 14(23), 2022. e-Pub 2022. PMID: 36497423.
- Salem AE, Fine GC, Covington MF, Koppula BR, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies. Cancers (Basel) 14(12), 2022. e-Pub 2022. PMID: 35740665.
- Fine GC, Covington MF, Koppula BR, Salem AE, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology-VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors. Cancers (Basel) 14(12), 2022. e-Pub 2022. PMID: 35740501.
- Wiggins RH, Hoffman JM, Fine GC, Covington MF, Salem AE, Koppula BR, Morton KA. PET-CT in Clinical Adult Oncology-V. Head and Neck and Neuro Oncology. Cancers (Basel) 14(11), 2022. e-Pub 2022. PMID: 35681709.
- Covington MF, Koppula BR, Fine GC, Salem AE, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology: II. Primary Thoracic and Breast Malignancies. Cancers (Basel) 14(11), 2022. e-Pub 2022. PMID: 35681669.
- Koppula BR, Fine GC, Salem AE, Covington MF, Wiggins RH, Hoffman JM, Morton KA. PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies. Cancers (Basel) 14(11), 2022. e-Pub 2022. PMID: 35681647.
- Cai ZJ, Salem AE, Wagner-Bartak NA, Elsayes KM, Negm AS, Rezvani M, Menias CO, Shaaban AM. Sciatic foramen anatomy and common pathologies: a pictorial review. Abdom Radiol (NY) 47(1):378-398, 2022. e-Pub 2022. PMID: 34664097.
- Salem AE, Zaki YH, El-Hussieny G, ElNoueam KI, Shaaban AM, Koppula BR, Bustoros M, Salama M, Elsayes KM, Morton K, Covington MF. An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features. Cancers (Basel) 13(22), 2021. e-Pub 2021. PMID: 34831006.
- Salem AE, Zaki YH, El-Hussieny G, ElNoueam KI, Shaaban AM, Koppula BR, Yang M, Salama M, Elsayes KM, Covington MF. Uncommon Variants of Mature T-Cell Lymphomas (MTCLs): Imaging and Histopathologic and Clinical Features with Updates from the Fourth Edition of the World Health Organization (WHO) Classification of Lymphoid Neoplasms. Cancers (Basel) 13(20), 2021. e-Pub 2021. PMID: 34680362.
- Diab M, Navin P, Wang M, Bath B, Hudson E, Salem A, Revzin M, Caoili E, Jimenez C, Elsayes K. Imaging of Cushing Syndrome.
- Diab M, Navin P, Wang M, Bath B, Hudson E, Salem A, Revzin M, Caoili E, Jimenez C, Elsayes K. "Functional Adrenal Pathologies: Imaging Approach to Clinical and Biochemical Phenotypes"(ID# RG-26-0100.R1), for publication in RadioGraphics.
Other Articles
- DeSai, C, Salem, AE, Surasi, DS Incidental Detection of PSMA Uptake in Lipomatous Hypertrophy of the Interatrial Septum. Clinical nuclear medicine 51(9):e795-e796, 2026. PMID: 42257561.
- Salem, AE, Krebs, SS, Morton, KA Genioglossus Muscle Uptake on 18F-FDG PET/CT, Secondary to Hypoglossal Nerve Stimulation. Clinical nuclear medicine 51(8):e652-e653, 2026. PMID: 41432590.
- Salem, AE, Ramirez, S, Weston, B, Hussein, A, Krebs, SS Case Report: Management of a challenging case presenting with dysphagia after thyroidectomy requiring administration of liquid 131I via MIC-KEY low-profile tube-a multidisciplinary approach. Frontiers in Medicine 13, 2026. PMID: 41695167.
- Dalati, L, Shaaban, A, Salem, AE Splenogonadal Fusion Diagnosed By Tc-99m Heat-Denatured Red Blood Cell Scintigraphy. Clinical nuclear medicine Publish Ahead of Print, 2025. PMID: 41428327.
- Binneboese A, Salem A Ultrasound Appearance of Acute Hepatitis A: A Case Report in the Wake of a Recent Outbreak in Utah causing 2 Deaths. SM J 4(2):1086, 2018.
- Salem A, Bahir A, Ross V, Karl M, Louis-Martin B Retroperitoneal Intranodal Contrast Agent Injection for Lymphangiographic Imaging of the Thoracic Duct in View of Percutaneous Intervention, 2015. PMID: 26314649.
Book Chapters
- Salem A. PET/CT Technique and Imaging Issues. In: Diagnostic Imaging: Gynecology. 4th. Elsevier, 2025.
- Salem A, Rogers. In Diagnostic Imaging. In: Rectal Carcinoma. 2. Elsevier, 2019.
- Salem A, Roger. In Diagnostic Imaging. In: Anal Carcinoma. 2nd. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Esophageal Carcinoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Gastric Carcinoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Colon Cancer. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Lymphoma. 2. Elsevier, 2019.
- Salem A. In Diagnostic Imaging. In: Melanoma. 2. Elsevier, 2019.
- Salem A. Chapter 17: Theranostics. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 16: Regulatory. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 15: Radiopharmaceuticals. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 14: Instrumentation and QC. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 13: Physics. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 10: Lymphatic. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 4: Non PET Oncology. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 3: Parathyroid and Salivary Gland. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 2: Thyroid Cancer. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 1: Thyroid Benign Disorders. In: Clinical Nuclear Medicine Protocols and Clinical Applications. Med Blend Publishing.
- Salem A. Chapter 14: PET/CT In Hematoligic malignancies. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
- Salem A. Chapter 10: PET-CT Neuroendocrine Tumors. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
- Salem A. Chapter 9: PET-CT Sarcoma. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
- Salem A. Chapter 8: PET-CT Cutaneous and mucosal cancers. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
- Salem A. Chapter 6: F-18 FDG PET-CT in Thoracic Maligancies. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
- Salem A. Chapter 2: F-18 FDG PET in Pediatric Oncology. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
- Salem A. Chapter 1: PET Introduction. In: Clinical applications of PET/CT in Adult. Med Blend Publishing.
Patient Reviews
CV information above last modified October 30, 2026